Ironwood Pharmaceuticals Quarterly Balance Sheet
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ironwood Pharmaceuticals financial position
As of Jun 30, 2026, Ironwood Pharmaceuticals reported total assets of $285.1 million, down 16.9% from a year earlier against total liabilities of $447.0 million. Shareholders' equity was negative at -$161.8 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $79.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.06, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Ironwood Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 79.13M | 220.47M | 215.46M | 140.41M | 92.85M | 108.48M | 88.56M | 88.21M | 105.52M | 121.54M | 92.15M | 110.16M |
| Receivables | 112.73M | 105.84M | 46.74M | 120.37M | 86.17M | 39.77M | 81.89M | 76.20M | 58.11M | 72.02M | 129.12M | 124.55M |
| Total Current Assets | 199.20M | 332.29M | 274.18M | 273.84M | 191.75M | 160.58M | 182.37M | 178.60M | 178.18M | 208.17M | 233.29M | 253.61M |
| Property, Plant & Equipment | 2.91M | 3.17M | 3.41M | 3.67M | 3.93M | 4.26M | 4.50M | 4.79M | 5.07M | 5.29M | 5.58M | 5.63M |
| Intangible Assets | 1.63M | 1.84M | 2.04M | 2.25M | 2.45M | 2.66M | 2.86M | 3.07M | 3.27M | 3.48M | 3.68M | 3.89M |
| Total Assets | 285.13M | 434.57M | 396.90M | 396.06M | 342.95M | 327.21M | 350.91M | 389.52M | 395.62M | 438.82M | 471.07M | 524.06M |
| Accounts Payable | 911.00K | 3.24M | 2.90M | 1.61M | 1.39M | 5.83M | 2.13M | 3.24M | 3.23M | 6.22M | 7.83M | 4.70M |
| Total Current Liabilities | 32.85M | 236.31M | 242.22M | 242.50M | 232.53M | 48.10M | 38.85M | 49.38M | 45.51M | 252.44M | 276.10M | 280.58M |
| Long-Term Debt | — | — | — | 199.51M | 199.33M | 199.16M | 198.99M | 198.82M | 198.65M | 398.28M | 397.87M | 397.46M |
| Total Liabilities | 446.97M | 651.71M | 658.74M | 660.22M | 651.11M | 661.27M | 652.24M | 700.85M | 717.35M | 769.34M | 817.37M | 849.74M |
| Shareholders' Equity | -161.84M | -217.14M | -261.83M | -264.16M | -308.16M | -334.05M | -301.33M | -311.33M | -321.73M | -330.52M | -346.30M | -323.22M |
| Retained Earnings | -1.58B | -1.63B | -1.67B | -1.67B | -1.71B | -1.74B | -1.70B | -1.70B | -1.70B | -1.70B | -1.70B | -1.70B |
| Total Debt | — | — | — | 199.51M | 199.33M | 199.16M | 198.99M | 198.82M | 198.65M | 398.28M | 397.87M | 397.46M |
| Net Cash (Debt) | 79.13M | 220.47M | 215.46M | -59.10M | -106.48M | -90.68M | -110.43M | -110.61M | -93.12M | -276.74M | -305.71M | -287.30M |
| Shares Outstanding | 165.24M | 164.61M | 163.06M | 162.68M | 162.43M | 161.81M | 160.21M | 160.02M | 159.74M | 158.96M | 156.35M | 156.13M |
This table shows 12 quarterly periods of Ironwood Pharmaceuticals's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IRWD's reporting calendar. What is a balance sheet?